Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • ADVERTISEMENT FEATURE Advertiser retains sole responsibility for the content of this article

Functional proteomic exploration of the pancreatic tumour microenvironment

WATCH ON DEMAND

Quanterix

Cell–cell interactions in the tumour microenvironment are often mediated by ligand proteins secreted by one cell that are recognized by specific receptors presenting on neighbouring cells. This intercellular communication activates signaling pathways through the induction of dynamic posttranslational modifications such as phosphorylation. Meanwhile, dysregulation of ligand–receptor interactions in the tumour microenvironment is known to promote cancer growth and metastasis.

Mass-spectrometry-based proteomics are a robust approach for characterizing these signaling events on a global scale. However, proteomic studies of intercellular signaling directly from limited clinical tissue samples have been challenging.

In this webcast, Dr Ruijun Tian of the Southern University of Science and Technology will present the recent development of a series of clinical functional proteomic approaches toward this end.

Besides the recent discovery of leukaemia inhibitory factor (LIF) as a drug target and potential biomarker for pancreatic cancer, Dr Tian’s work explores many secreted ligand–membrane receptor pairs, and provides valuable resources for systematically understanding dysfunctional signaling networks in the pancreatic tumour microenvironment in a context closer to physiological conditions than was previously possible. Based on the extremely sensitive Simoa system, he is actively exploring a new biomarker panel in combination with LIF for early diagnosis of pancreatic cancer.

You will learn:

• The role of LIF as a drug target and potential biomarker for pancreatic cancer

• How these approaches expand our understanding of dysfunctional signaling networks in the pancreatic tumour microenvironment

• How Simoa technology is significant in the investigation of novel biomarkers in conjunction with LIF for early detection of pancreatic cancer

Unable to join the live event? Watch on demand. Register now to ensure that you receive information on how to gain access after the live event.

This webcast has been produced by Quanterix, who retails sole responsibility for content. About this content.

Speaker

Ruijun Tian, Director, Research Center for Chemical Biology and Omics Analysis, SUSTech

Ruijun Tian

Ruijun Tian, PhD, is a professor at SUSTech and serves as the vice president of CNHUPO. He received the National Science Fund for Distinguished Young Scholars. His research focuses on proteomics technology development and applications in cell signaling and the tumor microenvironment. He has published over 100 papers, including in journals such as Nature, Cell Chemical Biology, PNAS and Nature Communications.

Moderator

Nikki Forrester, Freelance Science Writer and Editor

Moderator Nikki Forrester

Nikki Forrester is a science journalist who covers biology, natural history, climate, and the culture of academic research. She earned a Ph.D. in ecology and evolutionary biology in 2019.

Subjects

Latest on:

Search

Quick links